Best Applied Clinical Trials Podcasts (2025)

1
ACT Brief: AI Partnerships, Global Trial Access, and a New Option for Menopause Symptoms 2:33

Play Pause

10h ago2:33

2:33

In today’s ACT Brief, we spotlight expanding AI collaborations transforming life sciences, the role of patient-centric technology in improving global trial diversity, and the FDA’s approval of Bayer’s Lynkuet—the first dual neurokinin antagonist for menopausal hot flashes.By Applied Clinical Trials

1
Board Bombs - 3 Critical Questions to Prepare you For Boards and Empower your Practice 12:52

5h ago12:52

12:52

This podcast episode delves into the intricacies of pharmacological preparations for the NP board exams, specifically focusing on the implications of amitriptyline and its adverse effects. We meticulously analyze a clinical vignette involving a mock45-year-old woman who presents with dry mouth, constipation, and blurred vision following her initiat…

1
ACT Brief: Digital Consent, Global Diversity, and Clinical Setbacks Shape Today’s Clinical Research Landscape 2:36

3d ago2:36

2:36

Today’s ACT Brief explores how eConsent is modernizing participant engagement, highlights new data on global representation in breast cancer trials, and examines Moderna’s decision to halt its Phase III mRNA-1647 program after missing key endpoints.By Applied Clinical Trials

1
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition 2:32

4d ago2:32

2:32

In today’s ACT Brief, we revisit key insights from SCOPE Summit 2025 on AI and pragmatic trials, examine Genentech’s Phase III vamikibart data in uveitic macular edema, and highlight MJH Life Sciences’ acquisition of BPD Healthcare—expanding the bridge from discovery to delivery.By Applied Clinical Trials

1
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer 2:43

5d ago2:43

2:43

Today’s ACT Brief highlights how artificial intelligence is transforming trial data management, why biotechs are embracing parallel execution to accelerate development, and new Phase III results showing Imfinzi’s potential to redefine early-stage bladder cancer treatment.By Applied Clinical Trials

1
E188: How AI is Used in Digital Marketing 22:32

6d ago22:32

22:32

In this episode, we dive deep into how artificial intelligence (AI) is revolutionising digital marketing, from SEO optimisation to automated content creation, predictive analytics, and personalised campaigns. Our guest, Brandon Leibowitz, founder of SEO Optimisers, shares his expert insights on the future of AI-powered marketing, the best AI tools …

1
Exploring the Nuances of ADHD vs. Bipolar Disorder in Outpatient Care 28:16

7d ago28:16

28:16

Differentiating ADHD from Bipolar Disorder: A Case Study with Dale In this episode of 'Pearls and Prep,' host NPZ presents a detailed case study of a mock patient named Dale, exploring symptoms that could be indicative of ADHD or bipolar disorder. The session focuses on analyzing Dale’s history, behavior, and psychiatric background to understand th…

1
Special Edition: The Cardiovascular Outcome Trials – Origin and Perspective 31:05

6d ago31:05

31:05

In this special series on The Cardiovascular Outcome Trials our host, Dr. Neil Skolnik will discuss the history and importance of the Cardiovascular Outcome Trials for diabetes medications . In Part 1 we discuss an historical perspective with Dr. Steven Nissan and how this has lead to the CVOTs that change the way we practice from EMPA-REG in 2015 …

1
Targeting Head and Neck Atopic Dermatitis: Long-Term Outcomes with Tralokinumab

6d ago

—

Guest: Raj Chovatiya, MD, PhD Head and neck involvement in atopic dermatitis significantly affects patients’ daily lives, often driving greater stigma, discomfort, and disease severity. Given this region’s impact, a post hoc analysis of the ECZTRA 1 and 2 and ECZTEND trials examined tralokinumab and found that this IL-13 inhibitor not only provided…

1
Examining Delgocitinib for Chronic Hand Eczema: Results from the DELTA Trials

6d ago

—

Guest: Robert Bissonnette, MD, FRCPC The DELTA 1 and DELTA 2 trials examined the efficacy and safety of the topical pan-JAK inhibitor delgocitinib in patients with moderate to severe chronic hand eczema. Based on the findings, no new safety signals were observed, and nearly half of patients achieved a 75 percent improvement in HECSI scores as well …

1
Applying Guidelines to Chronic Hand Eczema Care: A Case-Based Approach

6d ago

—

Host: Raj Chovatiya, MD, PhD Guest: Benjamin Ehst, MD, PhD Chronic hand eczema presents persistent challenges, often driven by overlapping etiologies that complicate diagnosis and management. But by applying the latest guidelines, we can optimize both short- and long-term outcomes for our patients. Here with Dr. Raj Chovatiya to share a real-world …

1
Chronic Hand Eczema: Guideline-Based Strategies for Diagnosis and Management

6d ago

—

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Raj Chovatiya, MD, PhD Chronic hand eczema is a persistent and often multifactorial condition that poses substantial challenges for both patients and clinicians. To help clinicians overcome these challenges, U.S. and international guidelines are evolving to better direct the diagnosis and treatment of…

1
ACT Brief Weekly Recap: AI Innovation, Industry Resilience, and Supply Chain Readiness 2:07

7d ago2:07

2:07

In this week’s Applied Clinical Trials Brief, we highlight key findings from the 2025 State of the Industry Survey, explore how AI is transforming trial efficiency and patient engagement, and examine strategies to safeguard global research operations against rising tariff risks.By Applied Clinical Trials

1
Align, Apply, Adapt: Building Lasting Compliance with Troy Fugate 42:29

7d ago42:29

42:29

Send us a text In this episode of the Life Science Success Podcast my guest is Troy Fugate. The CCO of Compliance Insight, Inc., Troy brings 30+ years of FDA readiness, GMP, and quality leadership—turning complex requirements into practical, culture-shaping solutions and championing the Align–Apply–Adapt framework used across pharma, cell and gene …

1
Improving Psoriatic Disease Care Through Dermatology–Rheumatology Clinics

11d ago

—

Guest: Eric Ruderman, MD Combined dermatology–rheumatology clinics are transforming psoriatic disease care by streamlining communication, reducing patient burden, and enabling more targeted, effective treatments. To learn more about how these clinks work and why they matter for patients with psoriatic disease, tune in to hear from Dr. Eric Ruderman…

1
E187: Digital Guardians: Where AI Meets Cybersecurity 26:22

13d ago26:22

26:22

In this episode, we dive into the escalating war between AI and cybercrime — where artificial intelligence is both the ultimate defense and the greatest vulnerability. Our guest, Grant McCracken, founder of Dark Horse Security, reveals how AI-driven cybersecurity, machine learning detection systems, and automated threat analysis are transforming ho…

1
Board Bombs: 3 Great Practice Psychiatric Nurse Practitioner Board Prep Questions 12:26

14d ago12:26

12:26

🎧 Episode Title: 3 Board Bombs Every Psych NP Needs to Master: Illness Anxiety, Lamotrigine, and MAOI Protocols Episode Summary: Whether you're days from testing or deep in the trenches of your clinical prep, this episode delivers three case-based psychopharm scenarios designed to sharpen your diagnostic edge and reinforce high-risk, high-yield con…

1
ACT Brief Weekly Recap: Clinical Research Faces Funding Strain, Data Evolution, and a Shift in Outsourcing Models 2:09

14d ago2:09

2:09

Last week’s top stories explored how NIH’s shutdown plan is testing research resilience, why data infrastructure must precede AI adoption in 2025, and how sponsors are redefining outsourcing with hybrid resourcing models focused on flexibility, quality, and collaboration.By Applied Clinical Trials

1
RNA Secrets Unveiled: Byron Purse's Biotech Breakthrough Journey 43:54

16d ago43:54

43:54

Send us a text In this episode of the Life Science Success Podcast my guest is Byron Purse, co-founder of AlidaBio and professor of chemistry at San Diego State University who is pioneering innovative approaches to studying RNA modifications. Byron brings a wealth of expertise in synthetic and natural nucleic acid modifications, with a passion for …

1
Reimagining Clinical Operations Through Artificial Intelligence 6:37

17d ago6:37

6:37

In this episode of the ACT Podcast, we highlight a recent Q&A featuring Ibrahim Kamstrup-Akkaoui, vice president of data systems innovation at Novo Nordisk; and a feature article by Chris Driver, senior director of product management, Patient Suite at IQVIA, in which they both highlight how sponsors are adopting automation to streamline operations.…

1
Understanding Sebopsoriasis: Navigating the Clinical Overlap of Dermatoses

18d ago

—

Guest: Raj Chovatiya, MD, PhD Sebopsoriasis—where features of seborrheic dermatitis and psoriasis converge—remains a diagnostic gray area in dermatology. In this expert-led discussion, Dr. Raj Chovatiya explores the clinical nuances, distinguishing features, and immunologic overlap of these conditions. Dr. Chovatiya is a Clinical Associate Professo…

1
Advancing Care for Coexisting Psoriasis and Seborrheic Dermatitis

18d ago

—

Guest: Raj Chovatiya, MD, PhD Seborrheic dermatitis and psoriasis often overlap in presentation and location, making accurate diagnosis and effective treatment essential. Hear from Dr. Raj Chovatiya as he shares the latest evidence on non-steroidal therapies, addresses limitations of traditional treatments, and offers practical guidance for managin…

1
Special Edition_ MASH Part 1 - Screening 20:16

19d ago20:16

20:16

In this special series on Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-associated steatohepatitis (MASH) our host, Dr. Neil Skolnik will discuss Epidemiology, Importance, Screening and treatment of MASH. This special episode is supported by an independent educational grant from Boehringer Ingelheim. Pre…

1
E186: How Manufacturing Innovation is Making Personalized Medicine Scalable and Affordable 33:24

20d ago33:24

33:24

1
From Volcanoes to Nightmares: A Deep Dive on Prazosin 27:59

20d ago27:59

27:59

1
ACT Brief Weekly Recap: AI Monitoring, Biotech Scaling, and Site Interoperability Lead This Week’s Top Stories 2:09

22d ago2:09

2:09

A look back at last week’s most-viewed content highlights how AI-driven monitoring could improve management of cytokine release syndrome in oncology, how biotech startups are leveraging scalable platforms to accelerate clinical trial operations, and why interoperability challenges remain a top concern for research sites.…

1
Diabetes Core Update Oct 2025 27:46

24d ago27:46

27:46

This issue will review: 1. Once-weekly Ultra-processed Foods and Diet Quality in Association With Long-term Weight Change and Progression to Type 2 Diabetes Among Individuals With a History of Gestational Diabetes Mellitus—A Prospective Study 2. Plant-Based Dietary Patterns Associated With Reduced Risk of All-Cause Mortality in Diabetes Subgroups 3…

1
E185: Use of xAI in Small Cohort Clinical Trials to Identify Biomarkers of Best Responders 32:06

27d ago32:06

32:06

In this episode, we explore how Explainable AI (XAI) is revolutionizing drug development, rare disease research, and precision medicine. Our guest, Frédéric Parmentier, Vice President of Data Science at Ariana Pharma, shares how their Explainable Artificial Intelligence (XAI) platform, KEM (Knowledge Extraction and Management), helps uncover critic…

1
ACT Brief Weekly Recap: Data Innovation, Cybersecurity, and Contracting Bottlenecks in Clinical Trials 2:16

28d ago2:16

2:16

Last week’s top stories explored the push for digital-first clinical data systems, why cybersecurity must be central in CRO qualification, and how AI-driven contracting tools are helping sponsors cut delays and accelerate trial timelines.By Applied Clinical Trials

1
Revolutionizing Addiction Risk: Genetics, Tech, and Hope Unveiled 48:27

1M ago48:27

48:27

Send us a text In this episode of the Life Science Success Podcast my guest is James Piacentino, CEO of Thrive Genetics, Inc., a pioneering digital health startup focused on transforming addiction risk assessment through genetic and behavioral science. James brings a unique blend of entrepreneurial experience, technical expertise, and personal miss…

1
E184: How Contactless AI Sleep Monitoring is Transforming Patient Data Collection and Drug Development in Clinical Trials 25:27

1M ago25:27

25:27

How can AI-powered sleep monitoring transform clinical trials, drug development, and healthcare at home? In this episode, Jonas Krauss, Vice President of Business at Sleepiz AG, joins us to explore how contactless AI monitoring is redefining the way researchers and clinicians collect and analyze sleep data, vital signs, and patient health trends. U…

1
The Intricacies of Diagnosing Anxiety Disorders 31:49

1M ago31:49

31:49

Navigating Complex Diagnoses: A Case Study on OCD In this episode of Pearls and Prep, the host presents a mock case study featuring 'Sarah,' a fictional patient struggling with academic performance, overwhelming anxiety, and obsessive-compulsive behaviors. The episode emphasizes the importance of gathering comprehensive information before jumping t…

1
ACT Brief Weekly Recap: Partnerships, Site Networks, and AI Reshaping Clinical Trials 2:34

1M ago2:34

2:34

This episode of the Applied Clinical Trials Brief highlights a new global collaboration between two industry leaders, explores how site networks can address enrollment and retention challenges, and examines how generative AI is transforming clinical study reporting.By Applied Clinical Trials

1
Special Edition - OSA Part 4 – Bringing it All Together 28:43

1M ago28:43

28:43

In this special episode on Obstructive Sleep Apnea our host, Dr. Neil Skolnik will discuss treatment of OSA. In Part 1 we discussed an overview of OSA, in Part 2 we discussed making the diagnosis, Part 3 was treatment, and in Part 4 we bring it all together with a case to explore clinical decision making for OSA. This special episode is supported b…

1
ACT Brief: Policy Shifts, FDA Inspections, and Tariffs Pose New Challenges for Clinical Trials 1:49

1M ago1:49

1:49

In this episode of the ACT Brief, we spotlight an earlier interview with Ron Lanton, partner at Lanton Law, in which he discussed how rising drug costs, reduced FDA inspections, and potential tariffs on active pharmaceutical ingredients could increase costs and slow progress across the clinical research landscape.…

1
Off the PHARM: Abilify Decoded: Insights into Its Unique Approach in Antipsychotic Therapy 19:56

1M ago19:56

19:56

This podcast delves into the intricacies of the medication Abilify, also known as Aripiprazole, elucidating its unique role as a dopamine serotonin system stabilizer and its differentiation from traditional antipsychotics. Abilify is characterized not merely by its capacity to block or stimulate receptors, but rather by its ability to modulate thei…

1
Financial Strategies for Life Science Startups: Insider Secrets Revealed! 54:52

1M ago54:52

54:52

Send us a text In this episode of the Life Science Success Podcast my guest is Josh Yelen, a CPA, MBA, and the Founder & CEO of Function, a strategic financial leadership and bookkeeping services company that supports businesses across various industries, including life sciences. With over two decades of experience in operations, accounting, financ…

1
E183: Accelerating Biomanufacturing with AI: Reducing Development Timelines from Years to Hours 34:32

1M ago34:32

34:32

Can artificial intelligence really cut biomanufacturing timelines from years to hours? The answer is yes — and it’s already happening. In this episode, we sit down with Justin Byers, founder and CEO of Axio BioPharma, to explore how AI-driven biomanufacturing is transforming the development of monoclonal antibodies, biologics, and vaccines. By leve…

1
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research 2:28

1M ago2:28

2:28

In this week’s Applied Clinical Trials Brief, we recap three top stories: Novo Nordisk’s stepwise approach to AI adoption, new perspectives on eClinical technology as a growth driver, and expert insights on how recent policy changes could impact research funding and future therapies.By Applied Clinical Trials

1
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials 2:36

2M ago2:36

2:36

In this episode of the Applied Clinical Trials Brief, Shipra Patel, global therapeutic area section head for endocrinology and global head of pediatrics at Parexel, shares insights on what makes a standout research partner, how cross-functional teams support GLP-1 studies, the role of real-world evidence, and why patient retention will be critical …

1
E182: Why Clinical Drug Development Keeps Failing 21:39

2M ago21:39

21:39

Over 90% of drugs fail during clinical development, costing billions and leaving patients without life-saving treatments. Why does the pharmaceutical industry face such a high drug development failure rate, and how can artificial intelligence change the story? In this episode, Vitalay Fomin, CEO and co-founder of Numenos AI, reveals how his team is…

1
A Deep Dive into Second Generation Antipsychotic (SGA) Augmentation for Incomplete Response in Major Depression 24:50

2M ago24:50

24:50

This podcast delves into the complexities of augmenting treatment for major depressive disorder (MDD) when standard selective serotonin reuptake inhibitors (SSRIs) yield an incomplete response. We explore the role of second-generation antipsychotics (SGAs) as adjuncts to enhance therapeutic efficacy. Specifically, we examine how these agents can ta…

1
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies 2:49

2M ago2:49

2:49

In this episode of the Applied Clinical Trials Brief, we recap our three most-viewed articles of the week—spotlighting Veeva and Merck’s push for platform-driven trial efficiency, Sunny Kumar’s perspective on barriers slowing decentralized adoption, and the evolving role of blood glucose meters and continuous glucose monitors in clinical research.…

1
Pharma Water Expert Reveals Groundbreaking Innovation Strategies! 47:30

2M ago47:30

47:30

Send us a text In this episode of the Life Science Success Podcast my guest is Nissan Cohen, a worldwide expert with over 45 years of experience in high purity water systems, pharmaceutical engineering, and water technology innovation. Nissan is the Owner of Biopharmaceutical Water Doc company and has made significant contributions to the field thr…

1
Diabetes Core Update – September 2025 29:27

2M ago29:27

29:27

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association's four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from …